Keith G. Oldroyd is a British interventional cardiologist whose career has been closely associated with cardiovascular care and research in Scotland. He is based in Glasgow and works at the West of Scotland Regional Heart and Lung Centre at the Golden Jubilee National Hospital. Over several decades, he has combined high-volume clinical practice with academic leadership and internationally recognised cardiovascular research.
Academic History
Professor Oldroyd qualified in medicine from the University of Aberdeen in 1982, earning the degree of MBChB. He later completed doctoral research and was awarded a Doctor of Medicine degree with honours. He is a Fellow of the Royal College of Physicians and Surgeons of Glasgow and a Fellow of the Society for Cardiovascular Angiography and Interventions.
He holds a personal Chair within the Institute of Cardiovascular and Medical Sciences at the University of Glasgow, reflecting his sustained academic contributions to cardiovascular medicine and interventional cardiology.
Career Overview
Professor Oldroyd is a Consultant Interventional Cardiologist at the West of Scotland Regional Heart and Lung Centre, Golden Jubilee National Hospital, one of the United Kingdom’s major tertiary referral centres for cardiovascular care. In 2007, he became the first Clinical Director of Cardiology at the newly established centre, playing a key role in shaping its clinical services and strategic direction.
From 2011 to 2014, he also served as Director of Research and Development, further strengthening the hospital’s research infrastructure and clinical trial activity. He currently leads on cardiovascular research for NHS Scotland, providing strategic oversight and leadership for national cardiovascular research initiatives.
His personal research interests include the clinical and experimental evaluation of novel drug-eluting stents and the use of invasive physiological indices of coronary stenosis severity to guide decision-making in the cardiac catheterisation laboratory. He has been a principal investigator in several landmark international clinical trials, including FAME, FAME 2, PRAMI, and LEADERS FREE. These studies have had a major impact on contemporary interventional cardiology practice and have been published in the New England Journal of Medicine.
In addition to his international trial leadership, Professor Oldroyd is currently the United Kingdom principal investigator for several ongoing studies, including two clinical trials investigating stem cell therapy in the setting of acute myocardial infarction.
Career Timeline
- 1982: Qualified in medicine from the University of Aberdeen
- Post-qualification: Specialist training in cardiology and interventional cardiology
- 2007: Appointed first Clinical Director of Cardiology, West of Scotland Regional Heart and Lung Centre
- 2011–2014: Served as Director of Research and Development
- Subsequent years: Appointed to a personal Chair at the University of Glasgow
- Current: Consultant Interventional Cardiologist and lead for cardiovascular research, NHS Scotland
- Current: UK Principal Investigator for multiple cardiovascular and stem cell therapy trials
Recognition
Professor Oldroyd is internationally recognised for his contributions to interventional cardiology and coronary physiology. His leadership in major clinical trials published in leading medical journals has directly influenced global practice guidelines and standards of care. He is widely respected for his role in advancing evidence-based interventional strategies and for his leadership within UK and international cardiovascular research communities.
Areas of Speciality
- Interventional Cardiology
- Coronary Physiology and Fractional Flow Reserve
- Drug-Eluting Stents
- Acute Myocardial Infarction
- Clinical Trials in Cardiovascular Medicine
- Stem Cell Therapy in Cardiology
Sources
